Volume 9
-
No. 5 November 2015
In this issue...• Dermatology: Three major indications propel partnering
• Regulatory red carpet rolls out for antibiotic developers
• Next-generation antibody platforms take off
-
No. 4 October 2015
In this issue...• Medtech partnering: Megamergers and digital health
• The realization of precision medicine
• Demand for cancer technologies drives dealmaking
-
No. 3 September 2015
In this issue...• Neuroscience set for deal spree
• Evolving approaches in age-related disorders
• Partnering to manipulate the microbiome
-
No. 2 June 2015
In this issue...• A record year for deals
• Regenerative medicine on the up
• Academic-industrial partnerships prosper
• Antibody deals: an update